age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
72.81897
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 6
|
under $11k
| 0
| 6,878
| 4,825.4375
| 5,418.42969
| 10
|
white
| 17.898438
| 10
| 0.826904
| 0.717896
| 1
| 1
| 0
|
yes
| 1
| 0.6
|
no dnr
| 9
| 47
| 31.796875
| 158
| 28
| 36.59375
| 354.8125
| 3.299805
| 3.199707
| 3.899902
| 136
| 7.349609
| 165
| 62
| 2,534
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 346
| 1
|
63.94498
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 4,836
| 3,275.541
| 3,678.50977
| 12
|
white
| 16.398438
| 24
| 0.897949
| 0.827881
| 1
| 1
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 5
| 141
| 8.898438
| 132
| 24
| 38.5
| 295.1875
| 3
| 0.699951
| 1.299805
| 137
| 7.529297
| 216
| 23
| 1,965
| 1
| 0
|
SIP>=30
| 0
| 535
| 0
|
73.336
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null |
under $11k
| 0
| 10,886
| 6,786.2812
| 7,725.66797
| 11
|
black
| 29.597656
| 39
| 0.584961
| 0.391968
| 1
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 7
| 114
| 19
| 111
| 40
| 35.79688
| 190
| 3
| 0.699951
| 2.799805
| 144
| 7.40918
| 204
| 50
| 910
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 100
| 1
|
61.72198
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| 5,234
| 3,014.6914
| 3,693.28906
| 16
|
white
| 13.699219
| 18
| 0.924927
| 0.872925
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 4
| 122
| 17.796875
| 120
| 36
| 38.39844
| 134
| 2.5
| 0.5
| 0.299988
| 145
| 7.379883
| 74
| 14
| 1,979
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 93
| 1
|
68.07098
|
male
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 6
| 9
|
under $11k
| 0
| 47,397
| 31,747.0938
| 40,763.0312
| 41.333313
|
white
| 20.097656
| 35
| 0.738892
| 0.590942
| 1
| 0
| 0
|
no
| 0.3
| 0.1
|
no dnr
| 15
| 126
| 11.298828
| 120
| 32
| 38.89844
| 167.5
| 2.299805
| 4.599609
| 0.699951
| 142
| 7.519531
| 96
| 17
| 1,045
| null | 2
|
adl>=4 (>=5 if sur)
| 2
| 531
| 0
|
64.99896
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 0
| 40,531
| 25,163.0469
| 28,500.7656
| 28
|
white
| 30.796875
| 60
| 0.689941
| 0.5979
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 15
| 123
| 15.398438
| 59
| 6
| 36.19531
| 293.3125
| 4.299805
| 0.599976
| 1.5
| 146
| 7.439453
| 202
| 24
| 4,240
| null | 1
|
no(M2 and SIP pres)
| 1
| 531
| 0
|
57.96298
|
male
| 1
| 13
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 100
| 50,618
| 31,324.4531
| 37,703.9062
| 52.5
|
white
| 37.5
| 67
| 0.021
| 0.001
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 13
| 69
| 13.699219
| 107
| 28
| 37.5
| 185.6875
| 2.799805
| 0.399963
| 1.5
| 130
| 7.429688
| 119
| 26
| 7.5
| null | 2
|
<2 mo. follow-up
| 2
| 13
| 1
|
53.82599
|
female
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 0
| 10
|
$11-$25k
| 0
| 21,187
| 12,924.2812
| 14,137.7656
| 29.5
|
white
| 22.296875
| 39
| 0.887939
| 0.81189
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 10
| 125
| 23.898438
| 107
| 34
| 36
| 260
| 3
| 1
| 0.699951
| 134
| 7.509766
| 156
| 16
| 1,685
| 0
| 4
| null | 4
| 530
| 0
|
26.91299
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
$25-$50k
| 0
| 20,458
| 13,595.0078
| 15,301.2656
| 12.333328
|
white
| 21.5
| 31
| 0.919922
| 0.889893
| 1
| 0
| 0
|
no
| 0.8
| 0.89
|
no dnr
| 15
| 79
| 3.5
| 76
| 20
| 36.5
| null | 3
| 5.299805
| 1.099854
| 130
| null | 97
| 7
| 3,050
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 529
| 0
|
57.79599
|
male
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 11
|
under $11k
| 100
| 114,737
| 75,503.9375
| 87,248
| 44.25
|
white
| 75.5
| 92
| 0
| 0
| 3
| 1
| 0
|
no
| 0.3
| 0.1
|
no dnr
| 40
| 111
| 13.298828
| 103
| 22
| 36
| 386
| 2.299805
| 0.599976
| 1.199951
| 133
| 7.469727
| 71
| 18
| 2,295
| null | 6
|
SIP>=30
| 6
| 528
| 0
|
65.94397
|
female
| 0
| 27
|
Coma
|
Coma
| 0
| 12
|
$11-$25k
| 94
| 86,330
| 55,693.9688
| 65,210.0938
| 32
|
white
| 24.597656
| 36
| 0.128998
| 0.081985
| 9
| 0
| 0
|
no
| 0.75
| 0.85
|
no dnr
| 27
| 67
| 11.898438
| 157
| 36
| 38.69531
| 97.5
| 1.799805
| 0.5
| 0.599976
| 133
| 7.529297
| 198
| 10
| 3,160
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 527
| 0
|
71.35394
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 3
| 12
|
$11-$25k
| 0
| 5,664
| 4,086.1523
| 5,531.9375
| 7.5
|
white
| 16.296875
| 14
| 0.814941
| 0.601929
| 1
| 1
| 0
|
metastatic
| 0.1
| 0
|
no dnr
| 8
| 118
| 8.5
| 120
| 28
| 37.69531
| 306.625
| 2.5
| 14.699219
| 0.699951
| 145
| 7.489258
| 74
| 10
| 4,655
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 350
| 1
|
39.15399
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 65,108
| 41,013.4688
| 47,491.8125
| 34
|
white
| 21.097656
| 16
| 0.902954
| 0.86792
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 21
| 49
| 5.299805
| 68
| 20
| 35
| null | 3.199707
| 0.5
| 1.299805
| 143
| null | 159
| 58
| 1,220
| null | 7
| null | 7
| 526
| 0
|
63.211
|
male
| 1
| 12
|
Lung Cancer
|
Cancer
| 2
| null |
under $11k
| 0
| 13,598
| 9,065.5
| 12,148.6797
| 14.5
|
black
| 30.199219
| 37
| 0.371948
| 0.08699
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
dnr after sadm
| 10
| 115
| 8.699219
| 80
| 28
| 36.39844
| 186.9375
| 4
| 1.799805
| 1.199951
| 139
| 7.40918
| 170
| 32
| 3,030
| null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
58.53
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 13
|
$11-$25k
| 0
| 4,163
| 0
| 0
| null |
black
| 18.597656
| 31
| 0.691895
| 0.401978
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 3
| 115
| 14.699219
| 67
| 42
| 39.39844
| 142
| 3.099609
| 7.599609
| 0.699951
| 142
| 7.429688
| 96
| 11
| 4,586
| null | null |
no(M2 and SIP pres)
| 2.467285
| 155
| 1
|
41.97098
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
>$50k
| 0
| 28,025
| 17,503.9375
| 21,088.6406
| 47.5
|
white
| 23.296875
| 46
| 0.856934
| 0.807983
| 4
| 0
| 0
|
no
| 0.37
| 0.23
|
no dnr
| 7
| 87
| 7.299805
| 72
| 24
| 37.59375
| null | null | null | 0.899902
| 136
| null | 211
| 17
| null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
42.31097
|
male
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
under $11k
| 0
| 11,722
| 7,771.1914
| 9,862.02344
| 20.5
|
white
| 31.796875
| 53
| 0.419983
| 0.300964
| 3
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 3
| 118
| 22
| 113
| 25
| 35.5
| 165
| 3.099609
| 1.199951
| 11.699219
| 141
| 7.389648
| 145
| 111
| 4
| 0
| 2
|
<2 mo. follow-up
| 2
| 8
| 1
|
72.60498
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 3
| 8
|
under $11k
| 0
| 1,733
| 1,235.1172
| 1,652.92969
| null |
white
| 31.699219
| 17
| 0.294983
| 0.047997
| 1
| 1
| 0
|
metastatic
| 0.1
| 0
|
dnr before sadm
| -1
| 99
| 4.699219
| 76
| 20
| 37.89844
| null | 4.699219
| 1
| 0.899902
| 141
| null | 97
| 14
| null | null | null |
<2 mo. follow-up
| 3.372559
| 29
| 1
|
48.27399
|
female
| 1
| 45
|
Coma
|
Coma
| 0
| 10
|
$25-$50k
| 94
| 91,330
| 60,467.9062
| 69,929.5
| 44
|
white
| 24.5
| 49
| 0.390991
| 0.316956
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 31
| 60
| 12.699219
| 64
| 30
| 38.5
| 134
| 2.699707
| 0.799927
| 0.599976
| 140
| 7.5
| 104
| 5
| 2,444
| null | 0
|
<2 mo. follow-up
| 0
| 45
| 1
|
65.40698
|
female
| 0
| 32
|
Coma
|
Coma
| 1
| 12
|
under $11k
| 44
| 75,896
| 51,033.0938
| 59,645.875
| 29
|
white
| 18.898438
| 9
| 0.523926
| 0.452942
| 14
| 0
| 1
|
no
| 0.65
| 0.65
|
no dnr
| 32
| 77
| 10
| 68
| 28
| 36.39844
| null | null | 1
| 1.199951
| 136
| null | 369
| 26
| null | null | 4
|
adl>=4 (>=5 if sur)
| 4
| 518
| 0
|
54.31097
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 8
|
$11-$25k
| 0
| 4,114
| 2,559.4043
| 3,203.91992
| 15
|
white
| 23
| 20
| 0.860962
| 0.769897
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 4
| 144
| 13.398438
| 65
| 36
| 39.19531
| 178
| 3.299805
| 0.899902
| 1.599854
| 133
| 7.469727
| 184
| 16
| 2,137
| 2
| null |
SIP>=30
| 1.838867
| 517
| 0
|
61.03198
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 4,608
| 2,287.1426
| 2,884.43945
| null |
white
| 15.398438
| 16
| 0.886963
| 0.81189
| 1
| 0
| 0
|
yes
| 0.4
| 0.3
|
no dnr
| 3
| 121
| 19.597656
| 144
| 48
| 38.39844
| 197.9375
| 2.799805
| 0.799927
| 2.799805
| 142
| 7.419922
| 170
| 39
| 2,525
| null | null |
no(M2 and SIP pres)
| 2.261231
| 516
| 0
|
45.55499
|
male
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 11
|
under $11k
| 0
| 16,900
| 10,686.7422
| 12,602.9297
| 29
|
white
| 27.597656
| 47
| 0.754883
| 0.611938
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 9
| 113
| 7.099609
| 96
| 24
| 35.29688
| null | 2.899902
| 0.599976
| 2.299805
| 137
| null | 66
| 35
| 3,550
| 0
| null | null | 0.494751
| 320
| 1
|
76.41595
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 17,222
| 9,349.5156
| 11,712.0156
| 27
|
hispanic
| 19.699219
| 6
| 0.787964
| 0.660889
| 1
| 0
| 0
|
yes
| 0.95
| 0.9
|
no dnr
| 6
| 66
| 9.5
| 78
| 26
| 36
| 212.875
| 3.099609
| 0.899902
| 1.399902
| 131
| 7.40918
| 137
| 33
| 2,581
| 1
| 0
|
SIP>=30
| 0
| 513
| 0
|
55.73999
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 4,888
| 3,340.1641
| 3,512.76953
| 7
|
white
| 27.296875
| 36
| 0.802979
| 0.682983
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 5
| 81
| 5.399414
| 68
| 18
| 37
| null | 3.199707
| 0.399963
| 4.299805
| 141
| null | 81
| 60
| null | 0
| null |
<2 mo. follow-up
| 0.494751
| 46
| 1
|
49.008
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 16
|
under $11k
| 0
| 3,640
| 2,666.0059
| 2,941.5293
| 11
|
black
| 10.898438
| 19
| 0.950928
| 0.916992
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 4
| 109
| 10.898438
| 111
| 40
| 37.69531
| 142.5
| null | null | 0.899902
| 135
| 7.389648
| 131
| 6
| 883
| 1
| null |
SIP>=30
| 1.166748
| 509
| 0
|
31.55399
|
female
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 0
| 38,997
| 25,602.6406
| 28,688.6094
| 19.333328
|
hispanic
| 30.5
| 37
| 0.827881
| 0.768921
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 22
| 63
| 200
| 156
| 32
| 39.09375
| null | 3.199707
| 0.899902
| 1.199951
| 140
| null | 101
| 9
| 4,600
| 2
| 0
|
SIP>=30
| 0
| 507
| 0
|
56.616
|
male
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 18
|
$25-$50k
| 0
| 19,741
| 12,691.1953
| 14,891.0391
| 24.5
|
white
| 17.796875
| 26
| 0.837891
| 0.734985
| 1
| 0
| 0
|
no
| 0.75
| 0.65
|
no dnr
| 12
| 157
| 17.796875
| 179
| 41
| 39.59375
| 215
| 3.399902
| 0.699951
| 1.299805
| 133
| 7.519531
| 315
| 18
| 1,264
| 1
| 1
| null | 1
| 507
| 0
|
66.78699
|
female
| 0
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
|
under $11k
| 9
| 26,886
| 18,592.5
| 22,514.9531
| 17.5
|
black
| 28.398438
| 52
| 0.367981
| 0.25
| 10
| 0
| 0
|
metastatic
| 0.5
| 0.4
|
dnr before sadm
| -4
| 105
| 11.099609
| 60
| 20
| 38.29688
| null | 3.399902
| 0.5
| 1.599854
| 137
| null | 463
| 29
| null | null | 7
| null | 7
| 507
| 0
|
74.13599
|
female
| 0
| 44
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 4
|
under $11k
| 9
| 71,806
| 47,299.75
| 51,366.7812
| 23.25
|
black
| 27.597656
| 52
| 0.655884
| 0.478943
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 44
| 121
| 19.796875
| 63
| 64
| 35.5
| 288
| 2.399902
| 1.699951
| 0.799927
| 141
| 7.469727
| 257
| 12
| 5,725
| 5
| 0
|
adl>=4 (>=5 if sur)
| 0
| 507
| 0
|
30.39
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 11
|
under $11k
| 0
| 6,106
| 4,069.7422
| 5,218.54688
| 10
|
white
| 28.796875
| 35
| 0.821899
| 0.709961
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 6
| 85
| 8.599609
| 92
| 20
| 37.39844
| null | 2.399902
| 1.599854
| 0.899902
| 132
| null | 100
| 12
| null | 1
| 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
26.35999
|
female
| 0
| 48
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 11
|
under $11k
| 0
| 95,201
| 59,971.8125
| 67,958.5
| 25.25
|
black
| 19.796875
| 19
| 0.962891
| 0.93689
| 1
| 0
| 0
|
no
| 0.85
| 0.7
|
no dnr
| 48
| 97
| 4.799805
| 100
| 28
| 36.79688
| 91.42188
| 3.699707
| 0.599976
| 0.799927
| 134
| 7.369141
| 162
| 10
| 2,100
| null | 4
|
SIP>=30
| 4
| 506
| 0
|
43.03897
|
female
| 0
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 10
|
under $11k
| 37
| 48,817
| 31,306.2031
| 35,121.6875
| 19.5
|
black
| 25.398438
| 45
| 0.426941
| 0.306946
| 19
| 0
| 0
|
yes
| 0.55
| 0.5
|
no dnr
| 7
| 101
| 6.799805
| 96
| 16
| 36
| null | 3.099609
| 0.799927
| 1.099854
| 135
| null | 80
| 27
| 2,050
| null | 0
|
no(M2 and SIP pres)
| 0
| 227
| 1
|
79.02496
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 12
|
under $11k
| 9
| 5,753
| 3,172.6074
| 3,622.81836
| 8
|
white
| 24.796875
| 19
| 0.427979
| 0.121994
| 1
| 0
| 0
|
metastatic
| 0.35
| 0.05
|
dnr after sadm
| 2
| 71
| 18.398438
| 80
| 20
| 36
| 308.6875
| null | null | 1.199951
| 140
| 7.439453
| 108
| 23
| null | 5
| 5
|
SIP>=30
| 5
| 83
| 1
|
23.11299
|
male
| 0
| 43
|
Coma
|
Coma
| 0
| 12
|
under $11k
| 61
| 104,075
| 66,718.4375
| 77,519.875
| 35.5
|
black
| 23.5
| 35
| 0.740967
| 0.692993
| 3
| 0
| 0
|
no
| 0.05
| 0.02
|
no dnr
| 43
| 107
| 11.798828
| 76
| 24
| 37.89844
| null | 3.599609
| 0.5
| 3.099609
| 135
| null | 104
| 33
| 5,300
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 503
| 0
|
44.42999
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 3,720
| 2,596.6738
| 2,879.49805
| 13
|
black
| 17.398438
| 9
| 0.92688
| 0.875977
| 1
| 1
| 0
|
no
| 0.99
| 0.9
|
no dnr
| 5
| 113
| 7.299805
| 104
| 24
| 39.59375
| null | 2.899902
| 0.5
| 0.799927
| 134
| null | 379
| 4
| 3,700
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 503
| 0
|
64.12
|
male
| 0
| 18
|
CHF
|
COPD/CHF/Cirrhosis
| 7
| 12
|
$11-$25k
| 0
| 40,679
| 21,071.2031
| 25,232.2188
| 20.666656
|
white
| 35.398438
| 73
| 0.545898
| 0.347961
| 4
| 1
| 0
|
no
| 0.05
| 0.01
|
dnr after sadm
| 14
| 125
| 3.899902
| 72
| 22
| 36.29688
| 309.5
| null | null | 1.199951
| 146
| 7.429688
| 108
| 27
| 2,075
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 503
| 0
|
54.19299
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 12,546
| 7,809.6836
| 8,627.97656
| 13
|
white
| 16.097656
| 13
| 0.929932
| 0.880981
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 10
| 80
| 4.899414
| 50
| 22
| 36.19531
| null | 3.599609
| 0.899902
| 1.5
| 152
| null | 94
| 16
| 1,695
| 3
| 4
|
<2 mo. follow-up
| 4
| 55
| 1
|
18.77599
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 31,368
| 19,824.9375
| 22,587.9688
| 41.5
|
white
| 29.898438
| 33
| 0.86792
| 0.821899
| 1
| 0
| 0
|
no
| 0.65
| 0.6
|
no dnr
| 12
| 94
| 17.097656
| 100
| 32
| 37.89844
| 46.66406
| 3.399902
| 1.099854
| 1.699951
| 142
| 7.549805
| 125
| 42
| 795
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 501
| 0
|
72.97998
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
|
under $11k
| 9
| 13,111
| 7,897.5391
| 8,604.72656
| 16.5
|
white
| 18.597656
| 25
| 0.831909
| 0.775879
| 1
| 1
| 0
|
no
| 0.5
| 0.2
|
dnr after sadm
| 3
| 81
| 8.5
| 58
| 20
| 36.19531
| null | 4.199219
| 1
| 1.199951
| 137
| null | 84
| 12
| null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 501
| 0
|
70.43695
|
female
| 1
| 7
|
Coma
|
Coma
| 3
| null |
under $11k
| 44
| 30,399
| 19,896.4531
| 22,794.8281
| 25.5
|
black
| 33.195313
| 73
| 0.093994
| 0.056
| 13
| 1
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 1
| 109
| 6.5
| 74
| 20
| 36.09375
| null | 3.099609
| 6.599609
| 1
| 134
| null | 109
| 11
| null | null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
67.86597
|
male
| 1
| 32
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 37
| 61,337
| 39,699.4375
| 44,266.5938
| 20.25
|
white
| 18.199219
| 37
| 0.776978
| 0.643921
| 2
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 32
| 153
| 4.699219
| 54
| 38
| 37.89844
| 319
| 3.199707
| 0.5
| 0.899902
| 142
| 7.459961
| 107
| 7
| 3,154
| null | 0
|
<2 mo. follow-up
| 0
| 32
| 1
|
25.54099
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
under $11k
| 0
| 14,621
| 9,416.0859
| 10,230.5234
| 17
|
asian
| 28.398438
| 29
| 0.866943
| 0.820923
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 9
| 121
| 20
| 60
| 24
| 36.69531
| 392
| 2.899902
| 0.399963
| 3.899902
| 137
| 7.399414
| 376
| 57
| null | 0
| null | null | 0.494751
| 498
| 0
|
67.61896
|
male
| 0
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 0
| 114,873
| 74,604.5625
| 85,581.0625
| 37
|
white
| 26
| 43
| 0.559937
| 0.447998
| 12
| 0
| 0
|
metastatic
| 0.4
| 0.3
|
no dnr
| 41
| 69
| 2.399902
| 66
| 20
| 34.5
| 280.9375
| 3.299805
| 0.799927
| 0.799927
| 141
| 7.55957
| 166
| 11
| null | null | 0
|
<2 mo. follow-up
| 0
| 58
| 1
|
44.09299
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 3
| 12
|
under $11k
| 0
| 3,904
| 2,738.0293
| 3,507.14844
| 13
|
black
| 11.5
| 11
| 0.834961
| 0.638916
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.6
|
no dnr
| 5
| 124
| 6.399414
| 146
| 36
| 35.69531
| 261.875
| 2.299805
| 2.799805
| 6.899414
| 143
| 7.209961
| 54
| 40
| 2,036
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 496
| 0
|
33.741
|
male
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
under $11k
| 0
| 88,800
| 58,121.7188
| 72,872.375
| 43.5
|
white
| 30.796875
| 47
| 0.779907
| 0.708984
| 5
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 28
| 119
| 14.599609
| 131
| 33
| 40.09375
| 131.09375
| null | null | 1.599854
| 151
| 7.479492
| 180
| 26
| 2,735
| null | 0
|
no(M2 and SIP pres)
| 0
| 494
| 0
|
49.09
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 0
| 10,245
| 6,872.3477
| 7,327.44922
| 9
|
white
| 35.195313
| 22
| 0.67688
| 0.581909
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 8
| 76
| 33.195313
| 124
| 10
| 38.79688
| 86.65625
| 1.899902
| 4.399414
| 1
| 143
| 7.459961
| 89
| 17
| 4,050
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 493
| 0
|
63.88797
|
male
| 0
| 75
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null |
under $11k
| 0
| 187,289
| 113,972.438
| 129,011.125
| 30.75
|
white
| 20.199219
| 30
| 0.844971
| 0.744995
| 4
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 75
| 100
| 4.799805
| 72
| 16
| 36.09375
| 504.75
| 5.199219
| 5.299805
| 1.099854
| 135
| 7.439453
| 155
| 13
| 4,150
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 492
| 0
|
73.88599
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 81,752
| 51,140.0625
| 62,188
| 64.5
|
white
| 39.195313
| 80
| 0.344971
| 0.228973
| 5
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 12
| 167
| 8.898438
| 122
| 10
| 38.09375
| 200
| 1.5
| 8.599609
| 0.799927
| 137
| 7.189453
| 197
| 27
| 1,548
| null | 1
|
<2 mo. follow-up
| 1
| 12
| 1
|
32.65198
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 23,825
| 15,030.7344
| 16,773.9375
| 19.333328
|
white
| 27.199219
| 29
| 0.861938
| 0.813965
| 1
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 18
| 155
| 10.699219
| 72
| 32
| 39.19531
| 370
| 3.199707
| 0.899902
| 3
| 142
| 7.40918
| 126
| 32
| 1,715
| 4
| null |
no(M2 and SIP pres)
| 3.183106
| 491
| 0
|
92.65399
|
female
| 1
| 8
|
Coma
|
Coma
| 1
| null |
under $11k
| 55
| 33,577
| 21,423.25
| 25,377.0156
| 39
|
white
| 17.796875
| 30
| 0.233978
| 0.168976
| 10
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 6
| 53
| 5.5
| 78
| 10
| 39
| 124
| 3.699707
| 0.599976
| 1.399902
| 130
| 7.279297
| 225
| 29
| 2,125
| null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
33.46997
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 3,483
| 2,353.5195
| 2,468.35938
| 11
|
white
| 15.699219
| 6
| 0.948975
| 0.912964
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 4
| 124
| 12.5
| 116
| 24
| 38.59375
| 276.625
| 3
| 0.5
| 1.099854
| 143
| 7.429688
| 135
| 20
| 1,288
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 490
| 0
|
39.62198
|
male
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 0
| 99,971
| 62,746.625
| 70,309.1875
| 33
|
black
| 22.699219
| 46
| 0.888916
| 0.848999
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 47
| 99
| 7.299805
| 120
| 24
| 36.59375
| 212.5
| null | null | 2.299805
| 139
| 7.389648
| 90
| 10
| 1,400
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 489
| 0
|
74.39294
|
female
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 15
|
under $11k
| 0
| 13,282
| 8,855.1875
| 11,715.9297
| 17.5
|
white
| 28.5
| 23
| 0.380981
| 0.091995
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.2
|
dnr after sadm
| 1
| 73
| 7.599609
| 64
| 24
| 35.59375
| 442.8125
| 2.799805
| 1.899902
| 1.099854
| 136
| 7.509766
| 73
| 26
| 2,375
| 0
| 2
|
<2 mo. follow-up
| 2
| 16
| 1
|
60.51199
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 8
|
$11-$25k
| 0
| 5,472
| 3,706.3887
| 3,897.24805
| 12
|
black
| 13.599609
| 14
| 0.922974
| 0.869995
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 6
| 63
| 5.799805
| 152
| 16
| 39.09375
| null | 2.599609
| 3.899902
| 0.799927
| 127
| null | 94
| 6
| 1,450
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 488
| 0
|
68.12
|
male
| 1
| 25
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 18
|
under $11k
| 9
| 25,188
| 17,244.2031
| 19,472.0156
| 7.5
|
white
| 33.5
| 59
| 0.359985
| 0.167999
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
dnr after sadm
| 17
| 108
| 6.899414
| 96
| 22
| 35.39844
| null | 2.599609
| 4.799805
| 0.5
| 126
| null | 94
| 1
| null | 0
| null |
<2 mo. follow-up
| 0.494751
| 25
| 1
|
60.04398
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
|
under $11k
| 0
| 15,198
| 10,064.9766
| 10,894.9453
| 41
|
white
| 23.898438
| 52
| 0.824951
| 0.765991
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 6
| 136
| 11.798828
| 133
| 36
| 36.5
| 125
| 2.099609
| 0.399963
| 3.799805
| 139
| 7.329102
| 120
| 72
| 1,237
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 169
| 1
|
70.56799
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 0
| 12,137
| 6,805.6562
| 7,839.60938
| 15
|
white
| 21.5
| 27
| 0.776978
| 0.643921
| 1
| 0
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 9
| 69
| 8.798828
| 80
| 20
| 36.79688
| null | 3.599609
| 1.199951
| 1.299805
| 143
| null | 65
| 33
| 850
| 1
| 0
|
adl>=4 (>=5 if sur)
| 0
| 481
| 0
|
50.543
|
female
| 0
| 21
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 3
|
$25-$50k
| 9
| 50,746
| 34,318.1875
| 41,470.5
| 29.666656
|
white
| 32
| 41
| 0.385986
| 0.266968
| 9
| 0
| 0
|
yes
| 0.75
| 0.6
|
no dnr
| 21
| 66
| 6.299805
| 109
| 25
| 36.29688
| 202.21875
| 2.699707
| 1
| 1.099854
| 132
| 7.389648
| 126
| 33
| 1,115
| 7
| 7
|
<2 mo. follow-up
| 7
| 39
| 1
|
72.50696
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 0
|
under $11k
| 0
| 14,569
| 7,082.6367
| 8,828.42969
| 20
|
white
| 23.199219
| 28
| 0.770996
| 0.634888
| 3
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 6
| 116
| 14.099609
| 147
| 26
| 36.79688
| 328.5625
| 4
| 0.699951
| 1
| 135
| 7.469727
| 109
| 16
| 1,750
| null | null | null | 3.085449
| 119
| 1
|
66.672
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$11-$25k
| 0
| 29,171
| 18,045.1094
| 22,454.75
| 19.333328
|
black
| 19.5
| 29
| 0.85791
| 0.80896
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 22
| 77
| 6.299805
| 77
| 20
| 36.19531
| 404.75
| 4.299805
| 1.099854
| 2.099609
| 134
| 7.399414
| 100
| 16
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 183
| 1
|
61.13898
|
male
| 0
| 8
|
Coma
|
Coma
| 0
| null |
under $11k
| 44
| 7,577
| 5,176.9258
| 5,870.35938
| 11
|
black
| 24.097656
| 30
| 0.529907
| 0.459961
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 8
| 60
| 18
| 74
| 10
| 36.39844
| 63
| 1.299805
| 2.599609
| 2.799805
| 146
| 7.319336
| 97
| 56
| 992
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 283
| 1
|
69.36896
|
female
| 0
| 13
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 9
| 14,009
| 9,544.2656
| 10,667.0859
| 17.5
|
white
| 27.398438
| 43
| 0.525879
| 0.325989
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 1
| 109
| 14.699219
| 125
| 22
| 36.5
| 353.3125
| 1.799805
| 0.5
| 1.5
| 132
| 7.369141
| 107
| 12
| 3,120
| 6
| 4
| null | 4
| 484
| 0
|
72.96594
|
male
| 0
| 18
|
Colon Cancer
|
Cancer
| 1
| 19
|
$25-$50k
| 0
| 26,584
| 19,455.9688
| 28,796.6562
| 23
|
white
| 33.5
| 49
| 0.429993
| 0.122986
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.6
|
dnr after sadm
| 17
| 137
| 10
| 122
| 12
| 38.09375
| 240
| 1.899902
| 1.199951
| 0.899902
| 149
| 7.539062
| 194
| 27
| 1,232
| 0
| 0
|
<2 mo. follow-up
| 0
| 49
| 1
|
68.54797
|
male
| 0
| 95
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 37
| 197,417
| 126,041.625
| 151,807.5
| 55.25
|
white
| 38.898438
| 42
| 0.228973
| 0.075989
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 95
| 61
| 104
| 176
| 26
| 39.29688
| 105
| 2.199707
| 2.399902
| 2.899902
| 141
| 7.319336
| 376
| 70
| 1,113
| null | null |
Coma or Intub
| 5.333008
| 481
| 0
|
79.12396
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null |
under $11k
| 100
| 18,622
| 11,870.8281
| 13,468.7656
| null |
black
| 82.390625
| 113
| 0
| 0
| 5
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 66
| 6.699219
| 50
| 30
| 35
| 404.0625
| 2.099609
| 0.599976
| 2.699707
| 136
| 7.279297
| 81
| 108
| 337
| null | null |
<2 mo. follow-up
| 2.645996
| 3
| 1
|
62.883
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 3,748
| 2,488.6074
| 2,575.55859
| 7
|
white
| 15
| 14
| 0.91394
| 0.85498
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 4
| 71
| 21.699219
| 109
| 26
| 38.29688
| 134.6875
| 2
| 0.799927
| 1.599854
| 134
| 7.429688
| 100
| 30
| 5,752
| 0
| null |
SIP>=30
| 0.494751
| 480
| 0
|
78.31897
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null |
under $11k
| 0
| 12,338
| 7,648.0586
| 8,438.74219
| 20.5
|
white
| 21.398438
| 55
| 0.771973
| 0.636963
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 1
| 60
| 9.5
| 118
| 40
| 36.19531
| 285.6875
| 2.399902
| 2.199707
| 1.399902
| 130
| 7.379883
| 124
| 50
| 966
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 480
| 0
|
69.21295
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 16
|
$11-$25k
| 0
| 3,566
| 2,432.3281
| 2,913.5293
| null |
white
| 21.699219
| 9
| 0.589966
| 0.270996
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 99
| 6
| 72
| 20
| 35.79688
| null | 3.199707
| 1.399902
| 1
| 138
| null | 331
| 13
| 2,600
| null | null |
no(M2 and SIP pres)
| 2.800293
| 118
| 1
|
58.76797
|
male
| 0
| 5
|
Coma
|
Coma
| 1
| 12
|
$11-$25k
| 55
| 14,700
| 8,925.7891
| 10,656.9844
| 29
|
black
| 20
| 34
| 0.606934
| 0.542969
| 1
| 1
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 5
| 109
| 4.699219
| 64
| 20
| 36.09375
| null | 3.899902
| 0.699951
| 1.599854
| 140
| null | 153
| 22
| 1,700
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 479
| 0
|
38.11899
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 9
| 47,093
| 28,861.0938
| 33,175.9375
| 30.333328
|
white
| 27.5
| 25
| 0.782959
| 0.711914
| 1
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 16
| 133
| 19.5
| 133
| 36
| 36.19531
| 223.0625
| 3.099609
| 0.899902
| 0.5
| 141
| 7.389648
| 161
| 9
| 1,425
| null | 0
|
no(M2 and SIP pres)
| 0
| 479
| 0
|
66.91296
|
female
| 1
| 26
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 86,018
| 52,848.6875
| 61,411.9688
| 32.25
|
white
| 23.5
| 32
| 0.790894
| 0.66394
| 3
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 26
| 103
| 7.599609
| 80
| 24
| 35.89844
| 220
| 3.699707
| 0.299988
| 1
| 132
| 7.399414
| 139
| 16
| 1,850
| null | 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
36.80798
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
under $11k
| 41
| 29,838
| 18,833.5156
| 21,812.75
| 35
|
white
| 32.398438
| 47
| 0.642944
| 0.542969
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 9
| 69
| 15.5
| 67
| 10
| 35.69531
| 502
| 1.899902
| 1.799805
| 0.699951
| 136
| 7.419922
| 182
| 13
| 1,915
| null | 0
|
no(M2 and SIP pres)
| 0
| 476
| 0
|
76.57996
|
male
| 1
| 7
|
Coma
|
Coma
| 2
| 10
|
$11-$25k
| 61
| 16,563
| 10,596.4062
| 12,530.3438
| 32
|
white
| 24
| 41
| 0.28595
| 0.215973
| 1
| 1
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 3
| 69
| 11.599609
| 171
| 55
| 38.79688
| 142.5
| 2.799805
| 0.899902
| 1.399902
| 144
| 7.519531
| 107
| 17
| 1,092
| null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
71.24396
|
female
| 0
| 35
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 12
|
under $11k
| 0
| 108,652
| 71,450.875
| 79,561.625
| 23.25
|
white
| 22.796875
| 37
| 0.536987
| 0.422974
| 31
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 2
| 126
| 6.399414
| 134
| 32
| 38
| 106.65625
| 2.199707
| 11.199219
| 0.899902
| 128
| 7.549805
| 134
| 5
| 575
| null | 2
| null | 2
| 474
| 0
|
67.25
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
| null | 0
| 2,763
| 1,765.1641
| 2,354.55859
| null |
white
| 21.5
| 28
| 0.838989
| 0.735962
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 69
| 24
| 126
| 22
| 36.69531
| 220
| null | 0.599976
| 1.199951
| 137
| 7.369141
| 160
| 40
| 1,560
| null | null |
no(M2 and SIP pres)
| 2.708984
| 473
| 0
|
52.698
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 21,141
| 12,759.8672
| 14,685.0781
| 33.5
|
white
| 27.597656
| 39
| 0.837891
| 0.734985
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 127
| 16.296875
| 107
| 24
| 38.19531
| 288
| 2.599609
| 1
| 2.099609
| 140
| 7.329102
| 81
| 63
| 3,993
| null | 3
|
no(M2 and SIP pres)
| 3
| 472
| 0
|
52.00497
|
male
| 1
| 7
|
Coma
|
Coma
| 1
| 8
|
$11-$25k
| 44
| 14,741
| 9,165.6875
| 10,467.9062
| 17
|
white
| 16.699219
| 29
| 0.763916
| 0.719971
| 1
| 0
| 0
|
no
| 0.4
| 0.35
|
dnr after sadm
| 4
| 0
| 11
| 150
| 31
| 38.79688
| 297.5
| 1.799805
| 4.199219
| 3.699707
| 125
| 7.379883
| 42
| 66
| 5,930
| null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
59.89297
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 3,672
| 2,393.9316
| 2,511.20898
| 6
|
black
| 14.5
| 17
| 0.917969
| 0.861938
| 1
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 4
| 135
| 14.898438
| 105
| 5
| 38.39844
| 356.625
| null | null | 0.699951
| 131
| 7.479492
| 144
| 13
| 1,618
| null | null | null | 3.274902
| 468
| 0
|
57.98499
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 12
|
$11-$25k
| 0
| 7,687
| 4,499.8242
| 5,196.07812
| 22
|
white
| 16.898438
| 32
| 0.892944
| 0.820923
| 1
| 1
| 0
|
yes
| 0.9
| 0.6
|
no dnr
| 5
| 120
| 3.799805
| 77
| 20
| 37
| null | 3.299805
| 1
| 1
| 134
| null | 176
| 10
| null | 0
| 1
| null | 1
| 415
| 1
|
72.31494
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
$11-$25k
| 0
| 17,686
| 10,106.5
| 12,971.2031
| 14.5
|
white
| 12.599609
| 18
| 0.908936
| 0.845947
| 1
| 1
| 0
|
no
| 0.99
| 0.9
|
no dnr
| 8
| 64
| 4.5
| 111
| 8
| 38.19531
| 523.75
| 2.599609
| 0.399963
| 0.599976
| 137
| 7.429688
| 83
| 10
| 4,105
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 468
| 0
|
54.32397
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 12,159
| 7,667.8555
| 8,439.94531
| 15.5
|
black
| 20.296875
| 41
| 0.901978
| 0.835938
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
dnr after sadm
| 6
| 110
| 3.5
| 122
| 28
| 37.89844
| null | 2.699707
| 0.399963
| 1.5
| 133
| null | 112
| 30
| 1,275
| 1
| 4
|
SIP>=30
| 4
| 466
| 0
|
60.30698
|
male
| 1
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 12
|
under $11k
| 26
| 63,465
| 39,629.4688
| 49,235.625
| 38.333313
|
white
| 33.796875
| 65
| 0.232971
| 0.132996
| 8
| 0
| 0
|
yes
| 0.7
| 0.7
|
dnr after sadm
| 7
| 83
| 0.699951
| 101
| 20
| 35.79688
| null | 3.599609
| 0.599976
| 1.299805
| 133
| null | 108
| 18
| null | 6
| 2
|
<2 mo. follow-up
| 2
| 14
| 1
|
63.258
|
male
| 1
| 51
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 37
| 128,478
| 79,063.25
| 91,306.6875
| 37.75
|
white
| 22
| 36
| 0.545898
| 0.432983
| 6
| 1
| 0
|
metastatic
| 0.5
| 0.4
|
dnr after sadm
| 51
| 140
| 15.099609
| 150
| 25
| 38.69531
| 314
| null | null | 1.199951
| 149
| 7.429688
| 163
| 31
| 3,680
| null | 3
|
<2 mo. follow-up
| 3
| 51
| 1
|
65.01599
|
male
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
|
under $11k
| 9
| 31,724
| 20,273.4844
| 25,110.5781
| 40
|
white
| 32.5
| 57
| 0.440979
| 0.32196
| 1
| 0
| 0
|
yes
| 0.2
| 0
|
dnr after sadm
| 7
| 69
| 0.799927
| 146
| 24
| 36.39844
| null | 2
| 1
| 0.699951
| 131
| null | 117
| 11
| 5,050
| null | 1
|
<2 mo. follow-up
| 1
| 10
| 1
|
32.12299
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 6,625
| 4,011.2188
| 4,399.70703
| 12
|
white
| 22.398438
| 28
| 0.944946
| 0.905884
| 1
| 0
| 0
|
no
| 1
| 0.75
|
no dnr
| 6
| 90
| 10.699219
| 76
| 20
| 35.89844
| null | 2.299805
| 0.5
| 1
| 131
| null | 127
| 17
| null | 0
| null | null | 0.494751
| 463
| 0
|
73.98999
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 9
| 4,497
| 3,107.4102
| 4,095.87891
| 13
|
white
| 27.898438
| 20
| 0.53894
| 0.21698
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 3
| 120
| 17.597656
| 71
| 26
| 38.69531
| 190
| 2.699707
| 0.799927
| 5.599609
| 144
| 7.319336
| 99
| 65
| 1,517
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 463
| 0
|
75.98395
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
under $11k
| 44
| 40,937
| 27,263.9688
| 32,782.125
| 30
|
black
| 29.796875
| 58
| 0.387939
| 0.268982
| 4
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 21
| 118
| 9.599609
| 55
| 10
| 37.69531
| 363.3125
| null | null | 0.5
| 134
| 7.419922
| 120
| 11
| 2,285
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 463
| 0
|
64.26599
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 6
|
under $11k
| 0
| 10,697
| 6,611.6211
| 8,725.60938
| 15
|
white
| 23.097656
| 24
| 0.833984
| 0.727905
| 1
| 1
| 0
|
no
| 1
| 1
|
no dnr
| 5
| 76
| 9.798828
| 130
| 20
| 36.5
| 200
| 3.299805
| 1.099854
| 1
| 137
| 7.449219
| 102
| 18
| null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 461
| 0
|
67.95898
|
male
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 2,667
| 1,682.0225
| 1,844.41992
| null |
white
| 14.898438
| 10
| 0.898926
| 0.830933
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 3
| 90
| 10.199219
| 116
| 20
| 36.29688
| null | 3.599609
| 0.399963
| 1.099854
| 136
| null | 106
| 17
| 1,700
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 461
| 0
|
57.383
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 15
|
under $11k
| 0
| 9,595
| 5,629.1094
| 7,239.08984
| 14
|
white
| 14.798828
| 23
| 0.920898
| 0.865967
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 3
| 131
| 5.899414
| 53
| 38
| 38.59375
| 158
| 2.599609
| 7
| 0.799927
| 137
| 7.399414
| 176
| 28
| 1,868
| 0
| 0
|
SIP>=30
| 0
| 461
| 0
|
65.51398
|
male
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 89,647
| 58,617.6562
| 66,263.625
| 26.666656
|
white
| 36.398438
| 64
| 0.215973
| 0.068985
| 37
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 15
| 110
| 16.398438
| 71
| 22
| 36.19531
| 172
| null | 0.5
| 0.899902
| 138
| 7.269531
| 97
| 13
| 2,190
| null | 0
|
no(M2 and SIP pres)
| 0
| 460
| 0
|
76.72296
|
female
| 0
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
|
under $11k
| 0
| 8,117
| 5,389.4609
| 6,440.42969
| 20
|
black
| 26.398438
| 26
| 0.552979
| 0.438965
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 99
| 8.298828
| 106
| 16
| 35.5
| 500
| 3.439941
| 5.299805
| 1.399902
| 130
| 7.509766
| 51
| 42
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 245
| 1
|
60.76398
|
female
| 0
| 88
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 1
|
under $11k
| 9
| 192,117
| 117,801.75
| 129,911.562
| 42.5
|
white
| 21.5
| 22
| 0.832886
| 0.776978
| 1
| 0
| 0
|
no
| 0.7
| 0.75
|
dnr after sadm
| 14
| 101
| 10.099609
| 72
| 24
| 36.59375
| null | 4.299805
| 0.599976
| 1.5
| 138
| null | 107
| 17
| 1,925
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 89
| 1
|
75.92297
|
male
| 1
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
| null | 0
| 210,541
| 138,336.5
| 174,062
| 49
|
white
| 25.398438
| 66
| 0.648926
| 0.549927
| 38
| 0
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 45
| 128
| 16
| 78
| 32
| 36.59375
| 228.5625
| 3
| 1
| 1.299805
| 114
| 7.379883
| 188
| 19
| 4,805
| null | 0
|
<2 mo. follow-up
| 0
| 47
| 1
|
24.69299
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 155,743
| 101,314.812
| 127,360.25
| 28.333328
|
white
| 22.5
| 35
| 0.848999
| 0.795898
| 68
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 24
| 126
| 3
| 77
| 28
| 38
| 267.8125
| 2.599609
| 5
| 0.899902
| 136
| 7.439453
| 85
| 13
| 2,975
| 0
| 0
| null | 0
| 455
| 0
|
57.24799
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 13
| null | 0
| 6,553
| 4,324.3398
| 4,882.61719
| 7
|
white
| 12.099609
| 3
| 0.882935
| 0.734985
| 1
| 0
| 0
|
metastatic
| 1
| 0.9
|
no dnr
| 5
| 99
| 0.699951
| 120
| 40
| 38.29688
| null | 2.099609
| 1.199951
| 0.899902
| 137
| null | 164
| 7
| 1,600
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 455
| 0
|
72.19995
|
male
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
under $11k
| 9
| 44,016
| 30,163.4062
| 38,612.875
| 27.5
|
white
| 25.097656
| 31
| 0.517944
| 0.40094
| 20
| 0
| 1
|
yes
| 0.5
| 0.5
|
dnr before sadm
| -9
| 117
| 4.199219
| 60
| 22
| 36.29688
| 196
| 2.099609
| 0.199982
| 2.299805
| 138
| 7.319336
| 117
| 62
| 1,150
| null | 7
|
<2 mo. follow-up
| 7
| 9
| 1
|
40.06598
|
male
| 0
| 48
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 159,555
| 98,485.4375
| 113,089.188
| 43
|
white
| 29.5
| 62
| 0.812988
| 0.750977
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 48
| 71
| 17.898438
| 84
| 20
| 36.89844
| null | 2.399902
| 20.398438
| 1
| 127
| null | 70
| 13
| null | null | 7
|
SIP>=30
| 7
| 453
| 0
|
66.26398
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 13,492
| 8,294.0156
| 9,444.0625
| 13
|
black
| 17.597656
| 25
| 0.785889
| 0.656982
| 4
| 1
| 0
|
metastatic
| 0.5
| 0.25
|
no dnr
| 5
| 69
| 10.298828
| 61
| 10
| 37.89844
| 190
| 3.099609
| 1.399902
| 1.099854
| 143
| 7.389648
| 118
| 11
| 4,375
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 114
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.